Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
generalStage IIA includes: T1, N1, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)
28
Centers
34
Active Trials
—
Cancer Funding
Top Centers for Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8(28)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 68.7 |
| 2 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 68.7 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 68.7 |
| 4 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 68.7 |
| 5 | University of Illinois Cancer CenterChicago, IL Active Research Program | 68.7 |
| 6 | Boston University Cancer CenterBoston, MA Active Research Program | 68.7 |
| 7 | Cancer Center at IllinoisUrbana, IL Active Research Program | 68.7 |
| 8 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 47.0 |
| 9 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 47.0 |
| 10 | NCI Comprehensive Active Research Program | 47.0 |
| 11 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 47.0 |
| 12 | NCI Comprehensive Active Research Program | 47.0 |
| 13 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 47.0 |
| 14 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 47.0 |
| 15 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 47.0 |
| 16 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 47.0 |
| 17 | NCI Clinical Active Research Program | 47.0 |
| 18 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 47.0 |
| 19 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 47.0 |
| 20 | UMass Memorial Health Cancer CenterWorcester, MA Active Research Program | 47.0 |
| 21 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 47.0 |
| 22 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program | 47.0 |
| 23 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 47.0 |
| 24 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 47.0 |
| 25 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 47.0 |
| 26 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 47.0 |
| 27 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 47.0 |
| 28 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 30.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →